UFA
ABBV icon

US Financial Advisors’s AbbVie ABBV Stock Holding History

US Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-280
Closed -$16K – 51
2016
Q1 		$16K Buy
280
+180
+180% +$10K 0.03% 176
2015
Q4 		$6K Sell
100
-22
-18% -$1.27K 0.01% 356
2015
Q3 		$7K Buy
122
+22
+22% +$1.43K 0.01% 278
2015
Q2 		$7K Hold
100
– – 0.01% 252
2015
Q1 		$6K Hold
100
– – 0.01% 291
2014
Q4 		$7K Buy
+100
New +$6.3K 0.01% 263

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

US Financial Advisors's ABBV Position: Q2 2016 in Review

US Financial Advisors sold out of AbbVie (ABBV) in Q2 2016, closing a stake of 280 shares — an estimated $16K sold.

US Financial Advisors first reported a position in ABBV in Q4 2014 and held it in 6 quarters. The position peaked at $16K in Q1 2016. 1,634 funds tracked by Wall St. Rank hold ABBV as of Q2 2016.

  • US Financial Advisors reported no remaining AbbVie position as of Q2 2016 after selling out during the quarter.
  • US Financial Advisors sold 280 AbbVie shares in Q2 2016, an estimated $16K.
  • US Financial Advisors first reported a position in AbbVie in Q4 2014 and held it in 6 quarters.
  • US Financial Advisors's AbbVie position peaked at $16K in Q1 2016.
  • 1,634 funds tracked by Wall St. Rank held AbbVie as of Q2 2016.

Based on US Financial Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.